Skip to main content

Published locations for Subcutaneous and IV daratumumab combos appear comparable in myeloma

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Subcutaneous and IV daratumumab combos appear comparable in myeloma

User login

  • Reset your password
  • /content/subcutaneous-and-iv-daratumumab-combos-appear-comparable-myeloma
  • /hematologynews/article/208926/multiple-myeloma/subcutaneous-and-iv-daratumumab-combos-appear
  • /oncologypractice/article/208926/multiple-myeloma/subcutaneous-and-iv-daratumumab-combos-appear
  • /hematology-oncology/article/208926/multiple-myeloma/subcutaneous-and-iv-daratumumab-combos-appear
  • /hematologytimes/article/208926/multiple-myeloma/subcutaneous-and-iv-daratumumab-combos-appear